BRUNI, COSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.983
EU - Europa 2.662
AS - Asia 710
AF - Africa 15
SA - Sud America 4
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.377
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.973
RU - Federazione Russa 1.107
PL - Polonia 494
IT - Italia 482
IE - Irlanda 244
CN - Cina 193
SG - Singapore 173
HK - Hong Kong 159
SE - Svezia 157
IN - India 71
JO - Giordania 47
CH - Svizzera 39
DE - Germania 36
VN - Vietnam 30
GB - Regno Unito 23
FI - Finlandia 22
RO - Romania 14
CI - Costa d'Avorio 12
TR - Turchia 12
ES - Italia 11
CA - Canada 10
KR - Corea 9
NL - Olanda 9
UA - Ucraina 7
JP - Giappone 6
BE - Belgio 3
BR - Brasile 3
FR - Francia 3
HU - Ungheria 3
NO - Norvegia 3
PT - Portogallo 3
AU - Australia 2
EG - Egitto 2
ID - Indonesia 2
TW - Taiwan 2
AR - Argentina 1
EU - Europa 1
GE - Georgia 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
MU - Mauritius 1
PH - Filippine 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 6.377
Salva come PNG Salva come JPEG
Città #
Santa Clara 673
Warsaw 494
Fairfield 337
Ashburn 245
Dublin 236
Chandler 205
Woodbridge 165
Singapore 148
Seattle 143
Florence 130
Cambridge 109
Houston 108
Hong Kong 100
Lawrence 87
Wilmington 87
Moscow 84
Altamura 81
Princeton 67
Beijing 53
Ann Arbor 48
Boston 48
Mumbai 39
Shanghai 35
Pune 28
Dong Ket 26
Buffalo 25
Milan 25
Bern 23
Rome 22
Boardman 19
San Diego 16
Yubileyny 16
Kent 15
Medford 15
Falls Church 14
Naples 13
Abidjan 12
Timisoara 11
Turin 11
Bologna 9
London 9
Norwalk 9
Redwood City 9
Seoul 9
Cagliari 8
Guangzhou 8
Helsinki 8
West Jordan 8
Andover 7
New York 7
Barcelona 6
Castelliri 6
Pisa 6
Catania 5
Los Angeles 5
Munich 5
Shenzhen 5
Basel 4
Chiusi 4
Erzurum 4
Hillsboro 4
Iesi 4
Jacksonville 4
Lucca 4
Minamimotomachi 4
Montesilvano Marina 4
Phoenix 4
Toronto 4
Trento 4
Washington 4
Bayburt 3
Bom Jardim 3
Brussels 3
Budapest 3
Campi Bisenzio 3
Düsseldorf 3
Lisbon 3
Oslo 3
Wuhan 3
Zurich 3
Acton 2
Bari 2
Baselga di Pinè 2
Bergamo 2
Bucharest 2
Cairo 2
Carpi 2
Castello di Godego 2
Chicago 2
Cinisello Balsamo 2
Dearborn 2
Hamburg 2
Hilversum 2
Ho Chi Minh City 2
Istanbul 2
Jakarta 2
La Jolla 2
Lissone 2
Macherio 2
Malmo 2
Totale 4.264
Salva come PNG Salva come JPEG
Nome #
Critical finger ischemia and myocardial fibrosis development after sudden interruption of sildenafil treatment in a systemic sclerosis patient. 252
Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis 249
The "myth" of loss of angiogenesis in systemic sclerosis: A pivotal early pathogenetic process or just a late unavoidable event? 185
GLI INTERVENTI INFERMIERISTICI RIVOLTI AI PAZIENTI AFFETTI DA MALATTIE REUMATICHE SOTTOPOSTI A TERAPIA CON FARMACI BIOLOGICI: REVISIONE SISTEMATICA DELLA LETTERATURA 169
Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells 149
18F-fluorodeoxyglucose positron-emission tomography/CT and lung involvement in systemic sclerosis 144
Vascular leaking, a pivotal and early pathogenetic event in systemic sclerosis: should the door be closed? 143
The challenge of pet therapy in systemic sclerosis: evidence for an impact on pain, anxiety, neuroticism and social interaction 135
Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study 133
Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS) 126
Decrease of LL-37 in systemic sclerosis: a new marker for interstitial lung disease? 126
The Renal Resistive Index in systemic sclerosis: Determinants, prognostic implication and proposal for specific age-adjusted cut-offs 125
Calcinosis in systemic sclerosis: subsets, distribution and complications 125
Effect of Dysmetabolisms and Comorbidities on the Efficacy and Safety of Biological Therapy in Chronic Inflammatory Joint Diseases 121
Evidence for a Derangement of the Microvascular System in Patients with a Very Early Diagnosis of Systemic Sclerosis 116
The safety of iloprost in systemic sclerosis in a real-life experience 114
Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study 112
Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis. 111
Pregnancy in systemic sclerosis (SSc): results of systematic review and meta-analysis 109
Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis 102
The renal resistive index, a new biomarker for the follow up of vascular modifications in Systemic Sclerosis 100
Increased plasma levels of the VEGF165b splice variant are associated with the severity of nailfold capillary loss in systemic sclerosis 97
Pleuroparenchymal fibroelastosis in rheumatic autoimmune diseases: a systematic literature review 97
Decreased circulating lymphatic endothelial progenitor cells in digital ulcer-complicated systemic sclerosis 96
Avascular bone necrosis: An underestimated complication of systemic sclerosis 92
Antioxidant agents help primary Raynaud's phenomenon 91
Early Detection of Cardiac Involvement in Systemic Sclerosis: The Added Value of Magnetic Resonance Imaging 91
Pleuroparenchymal fibroelastosis in patients affected by systemic sclerosis: What should the rheumatologist do? 87
Hydroxychloroquine and joint involvement in systemic sclerosis: Preliminary beneficial results from a retrospective case-control series of an EUSTAR center 84
Very early versus early disease: the evolving definition of the 'many faces' of systemic sclerosis. 84
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 82
The positive side of the coin: Sars-Cov-2 pandemic has taught us how much Telemedicine is useful as standard of care procedure in real life 82
Computed Tomography Predictors of Mortality or Disease Progression in Systemic Sclerosis–Interstitial Lung Disease: A Systematic Review 79
Combination therapy with Bosentan and Sildenafil improves Raynaud’s phenomenon and fosters the recovery of microvascular involvement in systemic sclerosis 78
Quantiferon (QFT) identifies latent tuberculosis (LTB) but does not help the evaluation of the efficacy of prophylaxis in inflammatory arthritides 78
Quantitative analysis of pulmonary vasculature in systemic sclerosis at spirometry-gated chest CT 76
Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience 76
IL CONTRIBUTO DELLA TELEMEDICINA ALLA GESTIONE DEI PAZIENTI REUMATOLOGICI DURANTE LA PANDEMIA DA SARS-CoV-2 74
Prognostic value of lung ultrasound B-lines in systemic sclerosis 72
Combination of denosumab and biologic DMARDs in inflammatory muscle-skeletal diseases and connective tissue diseases 71
Oral lactobacillus species in systemic sclerosis 70
A SYSTEMATIC LITERATURE REVIEW (SLR) ON NURSING SENSITIVE OUTCOMES IN SYSTEMIC SCLEROSIS 68
Bosentan blocks the antiangiogenic effects of sera from systemic sclerosis patients: an in vitro study 67
A systematic review of the literature on nursing sensitive outcomes in scleroderma: towards a structured path led by a nurse case manager 66
Lung ultrasound B-lines in systemic sclerosis: cut-off values and methodological indications for interstitial lung disease screening 66
Lung magnetic resonance imaging in systemic sclerosis: a new promising approach to evaluate pulmonary involvement and progression 66
Stressful life events at the onset and during the evolution of systemic sclerosis 64
The renal resistive index: A new biomarker for the follow-up of vascular modifications in systemic sclerosis 64
Alfabetizzazione sanitaria e pazienti affetti da Sclerosi Sistemica 63
Treatment of ulcers in systemic sclerosis 63
Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management 62
THE EXPERIENCE OF A RHEUMATOLOGY UNIT DURING THE COVID19 LOCKDOWN: TELEMEDICINE ALLOWS A SAFE FOLLOW UP OF PATIENTS WITH RHEUMATIC DISEASES 58
The multifaceted problem of pulmonary arterial hypertension in systemic sclerosis 58
Iloprost use and medical management of systemic sclerosis-related vasculopathy in Italian tertiary referral centers: results from the PROSIT study 58
The role of ultrasound in systemic sclerosis: On the cutting edge to foster clinical and research advancement 58
ASSESSMENT OF HEALTH LITERACY IN A COHORT OF SYSTEMIC SCLEROSIS (SSC) PATIENTS 58
ULTRASOUND (US) EVALUATION OF BOWEL VASCULOPATHY IN SYSTEMIC SCLEROSIS (SSC) 57
Digital Ulcers in Systemic Sclerosis 57
EFFICACY OF A SELF-TREATMENT PROTOCOL FOR FACE AND TEMPOROMANDIBULAR JOINTS REHABILITATION IN SYSTEMIC SCLEROSIS 56
Recent advances steer the future of systemic sclerosis toward precision medicine 55
Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS) 55
AB1540-HPR NURSING INTERVENTIONS FOR RHEUMATIC MUSCULOSKELETAL DISEASES (RMDS) PATIENTS ON BIOLOGIC THERAPY: A SYSTEMATIC LITERATURE REVIEW (SLR) 54
Switching from originator adalimumab to biosimilar SB5 in a rheumatology cohort: persistence on treatment, predictors of drug interruption and safety analysis 52
Very early and early diagnosis of systemic sclerosis 51
The Yin-Yang Pharmacomicrobiomics on Treatment Response in Inflammatory Arthritides: A Narrative Review 48
The Use and Utility of Machine Learning in Achieving Precision Medicine in Systemic Sclerosis: A Narrative Review 47
Serum Organ-Specific Anti-Heart and Anti-Intercalated Disk Autoantibodies as New Autoimmune Markers of Cardiac Involvement in Systemic Sclerosis: Frequency, Clinical and Prognostic Correlates 45
Patient preferences for systemic sclerosis treatment: A descriptive study within an Italian cohort 44
Kidney involvement in systemic sclerosis: From pathogenesis to treatment 43
Nursing interventions for patients with rheumatic and musculoskeletal diseases on biological therapies: a systematic literature review 42
To develop a definition and validated expert recommendations to diagnose primary heart involvement in systemic sclerosis - preliminary pathway to a T2T approach 39
Ultrashort Echo-Time Magnetic Resonance Imaging Sequence in the Assessment of Systemic Sclerosis-Interstitial Lung Disease 37
The role of lung biopsy for diagnosis and prognosis of interstitial lung disease in systemic sclerosis: a systematic literature review 35
The differential crosstalk of the skin–gut microbiome axis as a new emerging actor in systemic sclerosis 34
The Role of Bronchoalveolar Lavage in Systemic Sclerosis Interstitial Lung Disease: A Systematic Literature Review 34
The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis-Interstitial Lung Disease in the European Scleroderma Trial and Research Database 33
Systemic sclerosis and primary biliary cholangitis: Longitudinal data to determine the outcomes 33
Digital Ulcers and Ventricular Arrhythmias as Red Flags to Predict Replacement Myocardial Fibrosis in Systemic Sclerosis 32
null 2
Totale 6.527
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.187
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.187
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020533 0 0 0 0 77 69 74 74 73 59 95 12
2020/2021839 38 50 71 180 42 70 80 57 70 102 32 47
2021/2022415 12 20 30 20 25 49 8 39 17 26 58 111
2022/20231.071 100 263 58 55 54 158 154 37 98 17 44 33
2023/2024827 19 71 88 50 58 130 46 147 21 113 57 27
2024/20252.306 129 415 235 682 845 0 0 0 0 0 0 0
Totale 6.527